Joining forces to beat cancer in Asia
Three of the world’s biggest pharma companies are joining forces to try and combat Asia’s ‘cancer epidemic’ The figures are startling: Asia-Pacific makes up about half of the world’s cancer deaths and the region...
Social media and the pharma industry
Every other industry is getting on the social media bandwagon. But could social media actually prove beneficial to the world of pharma? Outside of the pharmaceutical industry, business is continually finding innovative ways to...
Pharma goes mobile: Making the most of the app opportunity
As smartphones and tablets take over, pharma needs a strategic understanding of how mobile solutions improve customer outreach and drive competitive advantage. Andrew Tolve reports. Andrew TolveThe popularity of smartphones like...
Can personalised medicine save the pharma sector?
Personalised medicine is making a comeback – but will it stick this time? It was supposed to be the great saviour of the pharma industry – personalised medicine, the salve that would heal the...
Utilising a CTMS to Create a Development Edge
As clinical trials become more globalised and complex, there is an increased need for investigators in all regions of the world, as well as for treatment-naïve patients. The industry faces demanding regulatory needs, as...
Scientist gets his mind around Alzheimer’s
It’s not known what causes the disease or how to cure it. And the stakes have never been higher. But one European neuroscientist is leading the charge to uncover new treatments for this neurodegenerative...
Rodent models meeting need for reduced drug attrition rates
What are the strategies for reducing drug attrition rates in the clinic through the application of transgenic rodent models?‘Fail early, fail often’. It’s a paradigm that has long attached itself to the drug discovery...
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure...
State of the industry and the future of the sales force
eyeforpharma asked some of our key speakers for their insights on the “state of the industry and the future of the sales force”. Here’s what they had to say...How do you see the industry...
Bottlenecks in vaccine development: Eliminate from the beginning
Promising vaccine candidates, rising global demand and preparations for the next pandemic influenza have brought vaccine’s role into focus in the past years and resulted in an impressive Pharma market share and revenue...